Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Bacteroides fragilis

Bacteriorhodopsines Bacteriosms Bactenostasis Bacteriostat Bacteriostatic agent Bacteriostatic water Bacteroides Bacteroides fragilis Bactofugation Bactrim Bactrin... [Pg.85]

Most /3-lactams, including carbapenems + L1 from Xanthomonas maltophilia, CcrA from Bacteroides fragilis... [Pg.193]

Small or large bowel E. coli, Klebsiella spp., Proteus spp. Bacteroides fragilis and other Bacteroides Clostridium. [Pg.1133]

Other bacteria. Intestinal bacteria may play a critical role in the metabolic activation of certain nitroaromatic compounds in animals (119) and several reports have appeared on the metabolism of nitro PAHs by rat and human intestinal contents and microflora (120-123). Kinouchi et al. (120) found that 1-nitropyrene was reduced to 1-aminopyrene when incubated with human feces or anaerobic bacteria. More recently, Kinouchi and Ohnishi (121) isolated four nitroreductases from one of these anaerobic bacteria (Bacteroides fragilis). Each nitroreductase was capable of converting 1-nitropyrene into 1-aminopyrene, and one form catalyzed the formation of a reactive intermediate capable of binding DNA. Howard ej al. (116) confirmed the reduction of 1-nitropyrene to 1-aminopyrene by both mixed and purified cultures of intestinal bacteria. Two additional metabolites were also detected, one of which appeared to be 1-hydroxypyrene. Recently, similar experiments have demonstrated the rapid reduction of 6-nitro-BaP to 6-amino-BaP (123). [Pg.381]

Tracer species a-Hemolytic streptococci E. coli Bacteroides fragilis group... [Pg.3]

Aerobic enteric bacteria and anaerobic bacteria are both pathogens in intraabdominal infection. Aerobic bacteria, particularly E. coli, appear responsible for the early mortality from peritonitis, whereas anaerobic bacteria are major pathogens in abscesses, with Bacteroides fragilis predominating. [Pg.470]

Bacteroides fragilis Prevotella intermedia Enterococcus faecalis A Enterococcus faecalis B... [Pg.122]

Rocha ER, Smith CJ. 1998. Characterization of a peroxide-resistant mutant of the anaerobic bacterium Bacteroides fragilis. J Bacteriol 180 5906-12. [Pg.142]

Complicated intra-abdominal infections (used in combination with metronidazole) caused by E. coli, viridans group streptococci, P. aeruginosa, K. pneumoniae, Enterobacter spec es, or Bacteroides fragilis. [Pg.1490]

Intra-abdominal Infections - Enterococcus faecalis, S. aureus (penicillinase-producing), Staphylococcus epidermidis, E. coli, Klebsiella sp., Enterobacter sp., Proteus sp., M. morganii, P. aeruginosa, Citrobactersp., Clostridium sp., Bacteroides sp. including Bacteroides fragilis, Fusobacterium sp. Peptococcus sp., Peptostreptococcus sp., Eubacterium sp., Proplonibacterium sp.. Bifidobacterium sp. [Pg.1529]

More severe infections - More severe infections, particularly those caused by Bacteroides fragilis, Peptococcus sp. or Clostridium sp. other than C. perfringens. 1.2 to 2.7 g/day in 2 to 4 equal doses. [Pg.1630]

Anaerobic infections Treaimeni of serious infections caused by susceptible anaerobic bacteria. Effective in Bacteroides fragilis infections resistant to clindamycin, chloramphenicol, and penicillin. [Pg.1654]

Which of the following cephalosporins would have increased activity against anaerobic bacteria such as Bacteroides fragilis ... [Pg.53]

It is a penicillinase susceptible and is principally indicated for serious infection caused by Pseudomonas aeruginosa. It is effective against certain other gram negative bacilli including Proteus species and Bacteroides fragilis. [Pg.321]

Bacteroides fragilis (Gram-negative) Clostridium difficile (Gram-positive)... [Pg.232]

Cefotetan, cefoxitin Intravenous, second-generation drugs, activity versus Bacteroides fragilis allows for use in abdominal/pelvic infections... [Pg.997]

Other synergistic antimicrobial combinations have been shown to be more effective than monotherapy with individual components. Trimethoprim-sulfamethoxazole has been successfully used for the treatment of bacterial infections and Pneumocystis jiroveci (carinii) pneumonia. 3-Lactamase inhibitors restore the activity of intrinsically active but hydrolyzable 3-lactams against organisms such as S aureus and Bacteroides fragilis. Three major mechanisms of antimicrobial synergism have been established ... [Pg.1110]

Rasmussen, B.A. Kovacs, E. Cloning and identification of a two-component signal-transducing regulatory system from Bacteroides fragilis. Mol. Microbiol., 7, 765-776 (1993)... [Pg.471]

Bacteroides fragilis - [ANTIBIOTICS - BETA-LACTAMS - CEPHALOSPORINS] pol 3)... [Pg.85]

Bacteroides fragilis Metronidazole, clindamycin Chloramphenicol, imipenem, beta- lactam-beta-lactamase-inhibitor combinations... [Pg.1172]

Beta-lactamase Aeromonas spp., Steno-trophomonas maltophilia, Bacteroides fragilis NA Potentiation of beta-lactams against strains expressing a metallo-beta-lactamase [26]... [Pg.502]


See other pages where Bacteroides fragilis is mentioned: [Pg.182]    [Pg.291]    [Pg.202]    [Pg.1233]    [Pg.8]    [Pg.218]    [Pg.228]    [Pg.471]    [Pg.1521]    [Pg.1545]    [Pg.39]    [Pg.531]    [Pg.546]    [Pg.410]    [Pg.273]    [Pg.156]    [Pg.19]    [Pg.990]    [Pg.194]    [Pg.440]    [Pg.83]    [Pg.50]    [Pg.208]    [Pg.702]    [Pg.703]    [Pg.76]    [Pg.1065]   
See also in sourсe #XX -- [ Pg.30 ]

See also in sourсe #XX -- [ Pg.122 ]

See also in sourсe #XX -- [ Pg.19 ]

See also in sourсe #XX -- [ Pg.347 ]

See also in sourсe #XX -- [ Pg.2479 ]

See also in sourсe #XX -- [ Pg.297 , Pg.298 ]

See also in sourсe #XX -- [ Pg.108 , Pg.118 , Pg.124 ]

See also in sourсe #XX -- [ Pg.175 , Pg.176 ]

See also in sourсe #XX -- [ Pg.14 , Pg.107 ]

See also in sourсe #XX -- [ Pg.188 , Pg.189 ]

See also in sourсe #XX -- [ Pg.83 ]

See also in sourсe #XX -- [ Pg.120 ]

See also in sourсe #XX -- [ Pg.28 ]

See also in sourсe #XX -- [ Pg.104 ]

See also in sourсe #XX -- [ Pg.28 ]

See also in sourсe #XX -- [ Pg.83 ]




SEARCH



Bacteroides

© 2024 chempedia.info